← Home / LIPOCINE INC. (LPCN)
Stock Analysis
LIPOCINE INC. (LPCN)
LPCN
LPCN · Market data
2.12 +0.47%
Track LPCN in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when LPCN price is:
52W Range Position
2%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-02 16:44 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
✓
Fundamentals
Moderate / Negative
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
2.28
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below —
Recent Company Events
SEC VERIFIED
Latest material filings
JUN
4
●
Management / Board
MEDIUM
LPCN board and management update
(the “Company”) approved the Sixth Amended and Restated 2014 Stock and Incentive Plan (the “2014 Plan”).
8-K Filing • SEC EDGAR
MAY
7
●
Financial Results
HIGH
Announces Financial Results for the
(NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the first quarter ended March 31, 2026 and provided a corporate update.
8-K Filing • SEC EDGAR
What's Driving LPCN?
📈 Technical recovery is improving
Momentum is Neutral. Watch 2.28 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 2.03 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
40.5
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 2.03 and resistance at 2.47. A move through resistance would be needed to materially improve the chart, while a break of support would keep the pressure side dominant.
Price Chart
LPCN — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$15.8M
Company size
EV
$11.7M
Debt-adjusted value
P/E
-1.4
Not meaningful
P/S
7.9
Balanced
P/B
0.7
Low book multiple
EV/Sales
5.8
Balanced
EV/EBIT
-1.0
Not meaningful
P/FCF
-1.6
Not meaningful
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Moderate
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
119,397
≈ Moderate
📈 Net Income
-3.67M
↘ Negative
🧮 EPS (Basic)
-0.54
↘ Negative
LIPOCINE INC.
Related Opportunities